ArkieMiasma on X
Covid Lists
Alex 💨CR Boxes Everywhere on X
Urgency Of Equity Toolkit
Te Mahau
(PDF) Is CO2 an Indoor Pollutant? Direct Effects of Low-to-Moderate CO2 Concentrations on Human Decision-Making Performance
SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventions | Swiss Medical Weekly
Children-and-schools1.pdf
Case Studies Archive | Purified Air
APPG-REPORT-SEPT-23.pdf
2023 Clean Indoor Air Expo
Long COVID research risks losing momentum – we need a moonshot
Column: Did Sweden beat the pandemic by refusing to lock down? No, its record is disastrous
Evaluation of science advice during the COVID-19 pandemic in Sweden
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
Novavax is here!
How the Novavax Vaccine Works (Published 2022)
The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
The Tree That Could Help Stop the Pandemic
The Updated COVID Vaccines Are Here: 10 Things to Know
Quick takes: Novavax COVID vaccine protection, COVID booster uptake, avian flu in 2 states
Should you pick Novavax’s COVID-19 shot over mRNA options?
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates
XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants
Protein Vaccine Demonstrates Less Reactogenicity than mRNA – A Real World Study
Notes from the Field: Safety Monitoring of Novavax...
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial